These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 31976814)

  • 1. Metabolic and Cardiovascular Effects of Switching Thiazides to Amlodipine in Hypertensive Patients With and Without Type 2 Diabetes (the Diuretics and Diabetes Control Study).
    Buscemi S; Buscemi C; Borzì AM; Cosentino L; Rosafio G; Randazzo C; Colomba D; Di Raimondo D; Pluchinotta FR; Parrinello G
    Metab Syndr Relat Disord; 2020 Mar; 18(2):110-118. PubMed ID: 31976814
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of an amlodipine/olmesartan treatment algorithm in patients with or without type 2 diabetes and hypertension (a secondary analysis of the BP-CRUSH study).
    Nesbitt SD; Shojaee A; Maa JF; Weir MR
    J Hum Hypertens; 2013 Jul; 27(7):445-52. PubMed ID: 23254596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative metabolic effects of hydrochlorothiazide and indapamide in hypertensive diabetic patients receiving ACE inhibitor therapy.
    Krum H; Skiba M; Gilbert RE
    Diabet Med; 2003 Sep; 20(9):708-12. PubMed ID: 12925048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial.
    Oparil S; Chrysant SG; Melino M; Lee J; Karki S; Heyrman R
    J Hum Hypertens; 2010 Dec; 24(12):831-8. PubMed ID: 20200547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prior Medications and the Cardiovascular Benefits From Combination Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High-Risk Hypertensive Patients.
    Brook RD; Kaciroti N; Bakris G; Dahlöf B; Pitt B; Velazquez E; Weber M; Zappe DH; Hau T; Jamerson KA
    J Am Heart Assoc; 2018 Jan; 7(1):. PubMed ID: 29301757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.
    Julius S; Kjeldsen SE; Weber M; Brunner HR; Ekman S; Hansson L; Hua T; Laragh J; McInnes GT; Mitchell L; Plat F; Schork A; Smith B; Zanchetti A;
    Lancet; 2004 Jun; 363(9426):2022-31. PubMed ID: 15207952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension.
    Agrawal R; Marx A; Haller H
    J Hypertens; 2006 Jan; 24(1):185-92. PubMed ID: 16331117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 52-week prospective, cohort study of the effects of losartan with or without hydrochlorothiazide (HCTZ) in hypertensive patients with metabolic syndrome.
    Racine N; Hamet P; Sampalis JS; Longo N; Bastien N
    J Hum Hypertens; 2010 Nov; 24(11):739-48. PubMed ID: 20147971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of switching from amlodipine to combination therapy with telmisartan and low-dose hydrochlorothiazide.
    Ando K; Isshiki M; Takahashi K;
    Hypertens Res; 2009 Sep; 32(9):748-52. PubMed ID: 19590506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice.
    Bramlage P; Fronk EM; Wolf WP; Smolnik R; Sutton G; Schmieder RE
    Vasc Health Risk Manag; 2015; 11():1-8. PubMed ID: 25565857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive effects of amlodipine and hydrochlorothiazide in elderly patients with ambulatory hypertension.
    Lacourcière Y; Poirier L; Lefebvre J; Archambault F; Cléroux J; Boileau G
    Am J Hypertens; 1995 Dec; 8(12 Pt 1):1154-9. PubMed ID: 8998248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of candesartan cilexetil/hydrochlorothiazide and amlodipine in patients with poorly controlled mild-to-moderate essential hypertension.
    Fogari R; Mugellini A; Derosa G;
    J Renin Angiotensin Aldosterone Syst; 2007 Sep; 8(3):139-44. PubMed ID: 17907102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.
    Jamerson K; Weber MA; Bakris GL; Dahlöf B; Pitt B; Shi V; Hester A; Gupte J; Gatlin M; Velazquez EJ;
    N Engl J Med; 2008 Dec; 359(23):2417-28. PubMed ID: 19052124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups.
    Assaad-Khalil SH; Najem R; Sison J; Kitchlew AR; Cho B; Ueng KC; DiTommaso S; Shete A
    Vasc Health Risk Manag; 2015; 11():71-8. PubMed ID: 25653536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [VALUE study underscores the significance of reaching aimed blood pressure values for minimizing cardiovascular risks].
    Praxis (Bern 1994); 2004 Oct; 93(42):1748. PubMed ID: 15529964
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy, safety, and effects on quality of life of bisoprolol/hydrochlorothiazide versus amlodipine in elderly patients with systolic hypertension.
    Benetos A; Consoli S; Safavian A; Dubanchet A; Safar M
    Am Heart J; 2000 Oct; 140(4):E11. PubMed ID: 11011336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, active-controlled, parallel-group comparison of valsartan and amlodipine in the treatment of isolated systolic hypertension in elderly patients: the Val-Syst study.
    Malacco E; Varì N; Capuano V; Spagnuolo V; Borgnino C; Palatini P;
    Clin Ther; 2003 Nov; 25(11):2765-80. PubMed ID: 14693303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telmisartan plus HCTZ vs. amlodipine plus HCTZ in older patients with systolic hypertension: results from a large ambulatory blood pressure monitoring study.
    Neldam S; Edwards C;
    Am J Geriatr Cardiol; 2006; 15(3):151-60. PubMed ID: 16687967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of amlodipine camsylate/losartan 5/100-mg versus losartan/hydrochlorothiazide 100/12.5-mg fixed-dose combination in hypertensive patients nonresponsive to losartan 100-mg monotherapy.
    Suh SY; Ahn T; Bae JH; Lim DS; Lee SU; Kim YK; Hyon MS; Kim WH; Han KR; Park HK
    Clin Ther; 2014 Oct; 36(10):1402-11. PubMed ID: 25146365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.